Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 9.02 MB
Add to list
  1. Search results
  2. Potential and pitfalls of non-viral m...

Potential and pitfalls of non-viral mRNA delivery for ocular therapies

Joke Devoldere (UGent)
(2019)
Author
Promoter
(UGent) and (UGent)
Organization

Downloads

  • Download
    2019-03-14 PhD final .pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 9.02 MB

Citation

Please use this url to cite or link to this publication:

MLA
Devoldere, Joke. Potential and Pitfalls of Non-Viral MRNA Delivery for Ocular Therapies. Ghent University. Faculty of Pharmaceutical Sciences, 2019.
APA
Devoldere, J. (2019). Potential and pitfalls of non-viral mRNA delivery for ocular therapies. Ghent University. Faculty of Pharmaceutical Sciences, Ghent, Belgium.
Chicago author-date
Devoldere, Joke. 2019. “Potential and Pitfalls of Non-Viral MRNA Delivery for Ocular Therapies.” Ghent, Belgium: Ghent University. Faculty of Pharmaceutical Sciences.
Chicago author-date (all authors)
Devoldere, Joke. 2019. “Potential and Pitfalls of Non-Viral MRNA Delivery for Ocular Therapies.” Ghent, Belgium: Ghent University. Faculty of Pharmaceutical Sciences.
Vancouver
1.
Devoldere J. Potential and pitfalls of non-viral mRNA delivery for ocular therapies. [Ghent, Belgium]: Ghent University. Faculty of Pharmaceutical Sciences; 2019.
IEEE
[1]
J. Devoldere, “Potential and pitfalls of non-viral mRNA delivery for ocular therapies,” Ghent University. Faculty of Pharmaceutical Sciences, Ghent, Belgium, 2019.
@phdthesis{8619674,
  author       = {{Devoldere, Joke}},
  language     = {{eng}},
  pages        = {{249}},
  publisher    = {{Ghent University. Faculty of Pharmaceutical Sciences}},
  school       = {{Ghent University}},
  title        = {{Potential and pitfalls of non-viral mRNA delivery for ocular therapies}},
  year         = {{2019}},
}